ARTELO BIOSCIENCES, INC.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$11.4M | -$10.1M | -$9.9M | -$10.3M | -$9.4M |
| Operating expenses | $11.4M | $10.1M | $9.9M | $10.3M | $9.4M |
| Cash from operations | -$8.5M | -$8.3M | -$8.2M | -$8.0M | — |
| Total assets | $2.8M | $4.7M | $13.0M | $20.4M | $28.3M |
| Total liabilities | $4.1M | $1.8M | $1.3M | $1.0M | $1.1M |
Shares outstanding 2.3M · Free float 96.0%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.